These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29685181)

  • 1. Serial MRIs provide novel insight into natural history of optic pathway gliomas in patients with neurofibromatosis 1.
    Sellmer L; Farschtschi S; Marangoni M; Heran MKS; Birch P; Wenzel R; Mautner VF; Friedman JM
    Orphanet J Rare Dis; 2018 Apr; 13(1):62. PubMed ID: 29685181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofibromatosis Type 1-Associated Optic Pathway Glioma in Children: A Follow-Up of 10 Years or More.
    Kinori M; Armarnik S; Listernick R; Charrow J; Zeid JL
    Am J Ophthalmol; 2021 Jan; 221():91-96. PubMed ID: 32283094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients.
    Thiagalingam S; Flaherty M; Billson F; North K
    Ophthalmology; 2004 Mar; 111(3):568-77. PubMed ID: 15019338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain gliomas, hydrocephalus and idiopathic aqueduct stenosis in children with neurofibromatosis type 1.
    Glombova M; Petrak B; Lisy J; Zamecnik J; Sumerauer D; Liby P
    Brain Dev; 2019 Sep; 41(8):678-690. PubMed ID: 31000370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optic pathway glioma and the sex association in neurofibromatosis type 1: a single-center study.
    Henning AM; Handrup MM; Kjeldsen SM; Larsen DA; Ejerskov C
    Orphanet J Rare Dis; 2021 Nov; 16(1):489. PubMed ID: 34809690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.
    Segal L; Darvish-Zargar M; Dilenge ME; Ortenberg J; Polomeno RC
    J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extensive central nervous system involvement in optic pathway gliomas in neurofibromatosis type 1.
    Shaikh F; Johnston D; Michaud J; Hurteau J; Vassilyadi M; Keene D
    Pediatr Blood Cancer; 2011 Oct; 57(4):688-6690. PubMed ID: 21465640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Use of Magnetic Resonance Imaging Screening for Optic Pathway Gliomas in Children with Neurofibromatosis Type 1.
    Prada CE; Hufnagel RB; Hummel TR; Lovell AM; Hopkin RJ; Saal HM; Schorry EK
    J Pediatr; 2015 Oct; 167(4):851-856.e1. PubMed ID: 26233602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history and clinical management of optic pathway glioma.
    Astrup J
    Br J Neurosurg; 2003 Aug; 17(4):327-35. PubMed ID: 14579898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment Endocrine Disorders Due to Optic Pathway Gliomas in Pediatric Neurofibromatosis Type 1: Multicenter Study.
    Santoro C; Perrotta S; Picariello S; Scilipoti M; Cirillo M; Quaglietta L; Cinalli G; Cioffi D; Di Iorgi N; Maghnie M; Gallizia A; Parpagnoli M; Messa F; De Sanctis L; Vannelli S; Marzuillo P; Miraglia Del Giudice E; Grandone A
    J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32294191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into optic pathway glioma vision loss from mouse models of neurofibromatosis type 1.
    Freret ME; Gutmann DH
    J Neurosci Res; 2019 Jan; 97(1):45-56. PubMed ID: 29704429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optic pathway glioma volume predicts retinal axon degeneration in neurofibromatosis type 1.
    Avery RA; Mansoor A; Idrees R; Trimboli-Heidler C; Ishikawa H; Packer RJ; Linguraru MG
    Neurology; 2016 Dec; 87(23):2403-2407. PubMed ID: 27815398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Presentation and Outcome of Patients With Optic Pathway Glioma.
    Robert-Boire V; Rosca L; Samson Y; Ospina LH; Perreault S
    Pediatr Neurol; 2017 Oct; 75():55-60. PubMed ID: 28847625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.
    Arnljots U; Nilsson M; Bolzani R; Benassi M; Sandvik U; Munoz DM; Blomgren K; Hellgren K
    PLoS One; 2024; 19(7):e0305548. PubMed ID: 38990917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurements of Retinal Nerve Fiber Thickness and Ganglion Cell Complex in Neurofibromatosis Type 1, with and Without Optic Pathway Gliomas: A Case Series.
    Sahinoglu-Keskek N; Altan-Yaycioglu R; Canan H; Coban-Karatas M; Erbay A; Yazıcı N; Alkan O
    Curr Eye Res; 2018 Mar; 43(3):424-427. PubMed ID: 29185816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical coherence tomography in the evaluation of neurofibromatosis type-1 subjects with optic pathway gliomas.
    Chang L; El-Dairi MA; Frempong TA; Burner EL; Bhatti MT; Young TL; Leigh F
    J AAPOS; 2010 Dec; 14(6):511-7. PubMed ID: 21168074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature.
    Friedrich RE; Nuding MA
    Anticancer Res; 2016 Aug; 36(8):4095-121. PubMed ID: 27466519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurofibromatosis type 1-associated optic pathway gliomas: pathogenesis and emerging treatments.
    Amato A; Imbimbo BP; Falsini B
    Eur Rev Med Pharmacol Sci; 2023 Jun; 27(12):5636-5653. PubMed ID: 37401302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative MRI criteria for optic pathway enlargement in neurofibromatosis type 1.
    Avery RA; Mansoor A; Idrees R; Biggs E; Alsharid MA; Packer RJ; Linguraru MG
    Neurology; 2016 Jun; 86(24):2264-70. PubMed ID: 27170570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic MRI in NF1 children under six years of age for the diagnosis of optic pathway gliomas. Study and outcome of a French cohort.
    Blanchard G; Lafforgue MP; Lion-François L; Kemlin I; Rodriguez D; Castelnau P; Carneiro M; Meyer P; Rivier F; Barbarot S; Chaix Y;
    Eur J Paediatr Neurol; 2016 Mar; 20(2):275-281. PubMed ID: 26774135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.